IPC Symposium

Date: Wednesday 28 September 2022
Time: 13.00-16.00 CET
Title: Psoriasis: What we have Learned and Where we are Going

Room 1

Program Chair

Lars Iversen (Denmark)

Speakers:
Jonathan Barker (UK)
Curdin Conrad (Switzerland)
Alexander Navarini (Switzerland)
Filip Rob (Czech Republic)

Lone Skov (Denmark)
Chris Griffiths (UK)
Peter van de Kerkhof (The Netherlands)

Part one: PROGRAM

13.00–13.05	Welcome and Introduction Lars Iversen (Denmark)
13.05–13-19	Psoriasis in the Last Millennium Peter van de Kerkhof (Netherlands)
13.19–13.33	Psoriasis and Genetics Jonathan Barker (UK)
13.33–13.47	Psoriasis and the Immune System Chris Griffiths (UK)
13.47–14.01	Current and Novel Treatments Filip Rob (Czech Republic)
14.01–14.15	Biomarkers in Psoriasis Treatment – Today and in the Future Lone Skov (Denmark)
14.15–14.29	Non-pharmacological Management Today and in the Future Alexander Navarini (Switzerland)
14.29–14.43	Long-term Remission, Inflammatory Memory & Disease Modification Curdin Conrad (Switzerland)
14.43–15.00	Panel Discussion All Faculty
15.00-15.10	BREAK

Part two: POSTER PRESENTATIONS

15.10–15.11	Introduction to Poster Presentations Lars Iversen (Denmark)
15.11	Blocking Interleukin-17 in Psoriasis: Real-world Experience from the PsoPlus Cohort Lisa Schots (Belgium)
15.18	IL-17A+ mast cells in resolved psoriasis Theresa Benezeder (Austria)
15.25	Genomic and epigenomic profiling of “invisible scar” in psoriatic resolved skin Ameneh Ghaffarinia (Hungary)
15.32	Pathogenic relationship between Psoriasis and Obesity: An ex vivo study Giulia Briatico (Italy)
15.39	Using single-cell transcriptomics to characterise early mechanisms of disease remission in psoriasis Luc Francis (UK)
15.46	Cytokine imbalance during targeted therapies for psoriasis and atopic dermatitis – the yin yang of Th17 and Th2 Francesco Messina (Switzerland)
15.53	Defining Paradoxical Psoriasis and Deep Tissue Immune Cell Profiling David Croitoru (Canada)
16.00	Closing comments and adjourn Lars Iversen (Denmark)